Paul Josephs is CEO at LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). They have made 1 open-market trade across 1 company since 2025, most recently 2026-05-20.
CIK 0002022547
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $98K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LFCR | 592,915 | $3.8M |
Shares reported on the most recent Form 4, priced at the 2026-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LFCR | BUY | 2025-01-08 | 2025-01-08 | $5.74 | $98K | +6.3% | -2.3% | -13.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.